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Objectives. To investigate orofacial and sensorial characteristics of patients with orofacial pain and healthy controls.
Study design. Caseecontrol. Seventy-five patients (61 women) who had chronic orofacial pain for more than 6 months
(i.e., idiopathic trigeminal neuralgia, burning mouth syndrome, persistent idiopathic facial pain, nonidiopathic neuropathic
pain, fibromyalgia or temporomandibular disorders were compared with 41 healthy subjects (19 women). They were
evaluated with a quantitative sensory testing protocol involving a combination of gustative, olfactory, thermal, mechanical and
pain stimuli. Mean pain duration in this population was 6.27  6.06 years. Orofacial characteristics (masticatory and articular
abnormalities), oral health and sensitivity to muscular palpation were assessed.
Results. The majority of patients (73.3%) had pain upon craniofacial muscle palpation and 46.7% had numbness. High cold
thresholds were observed with burning mouth syndrome and nonidiopathic neuropathic pain (P ¼ .017), while high tactile
thresholds were observed in persistent idiopathic facial pain patients (P ¼ .048). Persistent idiopathic facial pain and
temporomandibular disorders were associated with a low threshold for pain perception (P < .002). Several of these sensorial
alterations were associated with positive musculoskeletal findings.
Conclusions. Sensorial abnormalities were observed in neuropathic and somatic pain patients. The masticatory system is
associated with and may be a secondary cause of pain in such patients. (Oral Surg Oral Med Oral Pathol Oral Radiol 2013;
115:e37-e45)The evaluation of the somatosensory function in
patients with chronic orofacial pain has elucidated some
mechanisms that can be involved in the pathophysi-
ology of trigeminal chronic pain. Recently, several
studies have been conducted that investigated sensory
abnormalities using quantitative sensory testing (QST)
in these patients.1-3 QST is an important tool that
evaluates the conscious perception of stimuli, which
includes its central modulation, complementing data
from electrophysiology, electroencephalography and
functional imaging of the central nervous system.4
Neuropathic orofacial syndromes often have sensory
deﬁcits and/or gains. These alterations have been
demonstrated on patients with trigeminal neuralgia,5,6
burning mouth syndrome (BMS),7 trigeminal post-
herpetic neuralgia (PHN),8 atypical odontalgia,9 atyp-
ical facial pain,10 persistent idiopathic facial pain11 and
patients who had undergone surgical oral procedures
(third molar extractions, orthognatic surgeries).12-17
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tization.18,19 These alterations are not only somatosen-
sory, but gustative and olfactory modalities may be
affected.7,20,21 Thus there appears to be sensorial
interaction among trigeminal, olfactory, gustative,
vision and auditory inputs.22-28 However, there is
a lack of studies that have produced associations and/or
correlations between QST and clinical ﬁndings. In as
much as dental and myofascial pain are prevalent in the
population and can be associated with neuropathic
conditions, we sought to investigate the orofacial
characteristics and sensory thresholds of orofacial pain
patients compared with controls.
METHODS
Subjects
We enrolled 75 consecutive patients with orofacial pain
who had been diagnosed at the Orofacial Pain Clinic of
the Hospital das Clinicas of the School of Medicine,
University of São Paulo. Patients were referred to
the Clinic between April and December of 2009.Statement of Clinical Relevance
Myofascial pain in the masticatory system was often
found in chronic orofacial pain patients in associa-
tion with sensorial alterations. This suggests that
mechanisms associated with central sensitization
may be involved and could be important in targeting
the alleviation of symptoms.
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54.89  18.75 years old [mean  standard deviation
(SD)]. In the control group, 41 healthy subjects who
had not orofacial pain complaints were enrolled and
studied. Nineteen controls (46.3%) were women, and
their mean age was 63.90  20.33 years old
(mean  SD). The controls attended preventive medical
clinics of the hospital.
Inclusion criterion for the study group was orofacial
pain for more than 6 months related to a diagnosis of
idiopathic trigeminal neuralgia, BMS, persistent idio-
pathic facial pain, nonidiopathic neuropathic pain or
temporomandibular disorders that was made according
to the criteria of the International Headache Society.29
Eight patients had ﬁbromyalgia associated with the
orofacial pain and they had been diagnosed according
to the criteria of the American College of Rheuma-
tology.30 The healthy controls did not had any orofacial
or generalized pain complaint at the moment of the
evaluation or previously.
Exclusion criteria for both groups were systemic
medical conditions (except ﬁbromyalgia in the study
group) (e.g., diabetes mellitus, other chronic pain
syndromes, neurological or other rheumatological
conditions). All participants were informed about the
purposes of the study and signed the informed consent.
The protocol was approved by the local Ethics
Committee. Demographic data were compared using
Pearson’s Chi-square test (SPSS 17.0; SPSS Inc., IL,
USA). Ages were statistically similar between patients
and controls (P ¼ .260), however there were more
women in the patient’s group (P < .001).
The patients that had BMS, posttraumatic painful
neuropathy (PTN), temporomandibular disorders and
persistent idiopathic facial pain (PIFP) were not using
any medication within 6 months before the evaluation.
These patients were referred from other clinics and were
undiagnosed for their orofacial apin and not under non-
pharmacological treatments (e.g., acupuncture, physio-
therapy). Patients with idiopathic trigeminal neuralgia
(ITN) were taking carbamazepine (400-1200 mg daily)
and patients with trigeminal PHN and ﬁbromyalgia were
taking amitryptiline (25-150mg daily) for at least the last
6 months prior to the study with no dose variation. At the
time of the study, the controls were not taking analgesic
medication, and had not been so either for the period of
6 months just before the evaluation.
Instruments for orofacial evaluation
The questionnaires and exams were performed by one
researcher only, a dentist, who ensured the clear
understanding of the content by the participants before
starting the protocol.
All subjects underwent a standardized protocol for
the evaluation of the orofacial region, including maincomplaint, pain characteristics [location, quality, dura-
tion, descriptors, intensity by the Visual Analog Scale
(VAS), alleviation and aggravation factors], earache,
headache, generalized body pain, sleep disturbances.31
Masticatory complaints related to parafunctional habits,
laterality and the quality of mastication were also
investigated. The intensity of masticatory discomfort
was evaluated with the VAS.
The intraoral examination included the evaluation
of teeth, periodontal tissues, oral mucosa, tongue, lips,
and facial skin, prostheses, occlusion and functional
aspects, such as mandibular movements (mouth opening,
protrusion, laterality) and temporomandibular joint
(TMJ) exam (noises, spontaneous pain, or pain con-
comitant with movements). The muscular palpation of
the head and neck was performed at the bilateral
masseter, temporalis, digastrics, sternocleidomastoid,
trapezius, splenius and suboccipitals. The periodontal
exam was performed with adequate probes and the
diagnoses made in accordance to the criteria of the
AmericanAcademy of Periodontology.32 All participants
underwent this detailed investigation for differential
diagnosis with dental pain etiologies. Previous studies
have shown that they can be associated with the main
diagnosis of the patients.33
Sensory investigation
All subjects were interviewed about their perception of
sensorial abnormalities such as numbness, dysesthesia,
taste and smell complaints. The frequency of these
abnormalities (absent, eventual, frequent, or constant)
and the intensity (0-10 by VAS) were analyzed.7 This
protocol is important for neuropathic and non neuro-
pathic pain diseases because somatic pain also presents
sensitization and chroniﬁcation.18,19
QST. All subjects underwent a standardized protocol
of QST (7) which consists of 8 tests grouped as follows:
- gustative and olfactory thresholds;
- thermal detection thresholds for cold and warm
sensations;
- mechanical detection thresholds for touch and
vibration;
- mechanical pain sensitivity including superﬁcial
and deep pain thresholds.
The somatosensory testing was performed at the
3 trigeminal branches (ophthalmic: fronte 2 cmabove the
pupil, maxillary: cheek e 1 cm lateral to the nose wing,
and mandibular: chin skine 1 cm below the lip angle), at
the hand dorsum (1 cm lateral to the thumb basis) and the
anterior tibia skin (10 cm below the basis of patella). The
evaluation was performed bilaterally in all subjects.
All subjects were evaluated in the sitting position,
with the head resting at a ﬂat surface, and in a silent
room with acoustic protection and the door closed.
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All subjects were evaluated by the same researcher. The
participants were oriented to keep the eyes closed during
the exam, to be focused on the stimuli, and to their
location (face and mouth) and characteristics. Only the
researcher knew the order of the stimuli.
Gustative thresholds7: the following four substances,
corresponding to the 4 tastes, were tested. For each test,
one drop was applied at the tongue, starting with the low
concentration, interleaved with one drop of distillate
water, and the concentrations were tested until the
subject had detected and identiﬁed the stimulus. Sweet:
glucose (0.01 M; 0.032 M; 0.1 M; 0.32 M; 1.0 M); salty:
sodium chloride (0.01 M; 0.032 M; 0.1 M; 0.32 M;
1.0M); sour: citric acid (0.00032M; 0.001M; 0.0032M;
0.01 M; 0.032 M); bitter: urea (0.1 M; 0.32 M; 1.0 M;
3.2 M; 10.0 M).
Olfactory thresholds7,33: the subjects were evaluated
with isopropanol solutions in polyethylene bottles
interleaved with distillate water, starting with the low
concentration until the subject had detected the stim-
ulus; 0.09%, 13.0%, 23.0%, 35.0%, 53.0%, 70.0%.
Thermal detection: thermal testing was performed
using the MSA thermo test device (Somedic, Sweden).
The baseline temperature was 32C and the contact
square area of the thermode was 9  9 mm. Cold
detection threshold and warm detection threshold were
assessed using ramped stimuli 1C/s. The evaluation
consisted in 5 measurements for each thermal threshold,
and the means and standard deviations were considered
for the analysis.
Mechanical detection threshold: touch perception was
assessed using a set of standardized von Frey ﬁlaments
with rounded tips of 0.5 mm diameter, applied with an
electronic device (IITC, Woodland Hills, CA, USA).
Three measurements in g/mm2 were performed and the
means and SDs were considered for the analysis.
Vibration detection threshold: vibration testing was
performed using the electronic Vibrameter device
(Somedic, Sweden) with a vibrator of 650 g of weight
and a contact area of 1 cm2 perpendicularly applied
for the thresholds detection, using ramped stimuli
of 1 Hz/s. The method of calculation of vibration
threshold consisted in the mean between the appearance
and disappearance thresholds detected by the patient.
Pressure pain perception: deep pain thresholds were
measured with the electronic pressure algometer
(Somedic, Sweden) with a probe area of 1 cm2 which
was pressed on the skin with a ramp rate of 50 kPa/s.
Superﬁcial pain perception: superﬁcial pain thresh-
olds were determined using disposable needles of
8  10  0.5 mm, applied with an electronic device
(IITC, Woodland Hills, CA, USA). Three measure-
ments in g/mm2 were performed and the means and
SDs were considered for the analysis.Data analysis
The patients with PHN and PTN were both included in
the group trigeminal nonidiopathic neuropathic pain.
The mean ﬁgures, SDs and frequencies were computed
to summarize the distribution of numbers for each
variable. After the initial descriptive evaluation, vari-
ables were tested in relation to the normal distribution
by the KolmogoroveSmirnoff test and QeQ plots, and
the variables which had normal distribution were
analyzed by the one-way analysis of variance
(ANOVA) and Tukey’s Post-hoc test. Non-parametric
tests were Pearson’s Chi-square and Fisher’s exact test.
The Z test was used to identify signiﬁcant categories
after Chi-square test. The level of signiﬁcance was 5%.RESULTS
The distribution of age, gender, laterality and branch
affected according to the diagnostic can be observed in
Table I. There was high intensity of pain (VAS
8.08  2.60), which was often daily (52.6%). The most
common pain descriptors were shock-like (28.4%),
burning (17.2%) and throbbing (13.8%). Mandibular
activity during function was the most common wors-
ening factor (17.2%) and medication was the most
common alleviation factor (31.0%) (Table II).Orofacial evaluation
Forty-nine (65.3%) patients had headache compared to
9 (22.0%) controls (P ¼ .015); 49 patients (65.3%)
complained about difﬁculties to sleep compared to 20
(48.8%) controls (P ¼ .082). Figure 1 shows the
generalized pain complaints which were less frequent in
ITN and trigeminal nonidiopathic neuropathic pain than
the other groups (P ¼ .002).
Masticatory abnormalities were observed in all
patients (despite 14.6% of controls) (P < .001). The
mean intensity of masticatory discomfort of the patients
was 4.57  4.14 by the VAS (P < .001). Controls had
more bilateral mastication (39.8%) than the patients
(32.0%) (P < .05); 33 (44.0%) patients and 34 (82.9%)
controls reported good quality of mastication
(P ¼ .002) and the mean mouth opening of the patients
was 42.66  8.88 mm (21-62 mm) (P ¼ .278). Twenty-
four (32.0%) patients and 6 (14.6%) controls had
bruxism (P ¼ .045). Pain upon awakening was more
prevalent in ﬁbromyalgia (100%; 54.5%; P < .001) and
pain in mandibular movements was more frequent in
TMD (P < .009). Only 4 (9.8%) controls had pain upon
awakening and 2 (4.9%) controls had pain in mandib-
ular movements. Fifty-ﬁve (73.3%) patients had pain
during craniofacial muscular palpation compared with
only 9 (21.9%) controls (P < .001). The group of
patients that had less pain on palpation was trigeminal
nonidiopathic neuropathic pain (63.0%). Pain on facial
Table I. Age, gender, laterality, and branch affected according to the diagnosis (N ¼ 116)
Groups Age (years) Gender (%) Laterality (%) Branch affected (%)
ITN (N ¼ 29; 38.7%) 60.69  14.83 (29-87) 22 (75.9) women 18 (62.1) right 1 (3.4) V1
11 (37.9) left 9 (31.0) V2
9 (31.0) V3
8 (27.6) V2-3
2 (6.9) V1-2-3
TMD (N ¼ 11; 14.7%) 43.64  17.82 (23-69) 11 (100.0) women 2 (18.2) right e
6 (54.5) left
3 (27.3) bilateral
NINP (N ¼ 11; 14.7%)y 55.27  24.67 (15-84) 9 (81.8) women 4 (36.3) right 5 (45.5) V1
7 (63.6) left 1 (9.1) V2
3 (27.3) V3
1 (9.1) V1-2
1 (9.1) V2-3
BMS (N ¼ 8; 10.7%) 67.00  16.69 (37-88) 8 (100.0) women 8 (100.0) bilateral e
PIFP (N ¼ 8; 10.7%) 44.63  19.09 (14-73) 7 (87.5) women 5 (62.5) right
3 (37.5) left
Fibromyalgia (N ¼ 8; 10.7%) 47.00  1.16 (31-73) 8 (100.0) women 8 (100.0) bilateral e
P* .004 .001 <.001 <.001
ITN, idiopathic trigeminal neuralgia; TMD, temporomandibular disorder; BMS, burning mouth syndrome; PIFP, persistent idiopathic facial pain;
NINP, trigeminal nonidiopathic neuropathic pain; V1, ophthalmic branch; V2, maxillary branch; V3, mandibular branch; V1-2, ophthalmic and
maxillary branches; V2-3, maxillary and mandibular branches.
*Chi-square and Fisher’s exact tests.
yTrigeminal nonidiopathic neuropathic pain: 6 (7.3%) patients had trigeminal postherpetic neuralgia and 5 (6.1%) patients had trigeminal post-
traumatic painful neuropathy.
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TMD (P < .001).
There were no differences among the patients and
controls in articular noises at the TMJ (P ¼ .378). Eight
(19.5%) controls had TMJ popping and 6 (14.6%)
controls had TMJ crepitation, compared with 19
(25.3%) patients with TMJ popping and 9 (12.0%)
patients with crepitation (Table III).
The prevalence of edentulism was 30.7% in the
patient’s group, similar to the prevalence in the control
group (P ¼ .568). There were 6.7% patients with decay
and 2.7% with fractured teeth (P ¼ .799). Twenty-ﬁve
patients (33.3%) had periodontal disease; 7 (9.3%) had
gingivitis and 18 (24.0%) had periodontitis (P ¼ .630).
Patients with BMS had higher prevalence of dryness on
the oral mucosa (P ¼ .014) and higher prevalence of
ﬁssured tongue (P ¼ .003) than the controls (Table IV).
Sensory investigation
In this population, 35 (46.7%) patients and 2 (4.9%)
controls complained of facial numbness; mean intensity
6.67  2.79 (P < .001). These controls had eventual
numbness sensation at the face, compared to 21 patients
with constant numbness. Nine (12.0%) patients com-
plained of low taste sensation, 4 (5.3%) complained of
low taste and smell sensations, 2 (2.7%) had phantom
taste and 1 (1.3%) had pain associated with food
temperature. Nine (7.8%) subjects smoked.
Patients with trigeminal nonidiopathic neuropathic
pain had higher olfactory thresholds (12.1  4.3%) than
the controls (10.5  3.5%), and the patients withﬁbromyalgia (10.1  0.9%) had lower olfactory
thresholds than BMS (9.9  1.5%) and PIFP
(9.9  0.0%) (One-way ANOVA, P < .001). The
gustative evaluation of salty was the only that showed
differences: it was higher in the group of ﬁbromyalgia
(3.8  1.9 M) when compared to the other groups and
controls (2.8  0.8 M) (One-way ANOVA, P < .001).
Patients with BMS and NINP had higher cold thresh-
olds than the controls (P ¼ .017), and DFIP had higher
tactile thresholds than the controls (P ¼ .048; one-way
ANOVA) (Figure 2). There were no differences in warm
thresholds (P¼ .157) or in vibratory thresholds (P¼ .056;
one-way ANOVA). Deep pain thresholds of DFIP and
TMD were lower than the controls (P < .001), and DFIP
and ﬁbromyalgia had higher superﬁcial pain thresholds
than the controls (P ¼ .002) (Figure 3).
The QST comparison among the groups according to
the trigeminal branch showed the following differences:
A) the ophthalmic branch at both facial sides of NINP,
which included PHN patients, had higher cold thresh-
olds than the other groups (P ¼ .019); B) the patients
with TMD presented a correlation between low cold
thresholds at the ophthalmic branch and low deep pain
thresholds at the temporalis territory (P ¼ .015); C)
there was also a correlation between low deep pain
thresholds at the masseter territory of patients with
TMD and low vibration thresholds at the maxillary and
mandibular branches of these patients (P ¼ .008).
In the whole sample, there were positive correlations
among cold, warm (P < .001), tactile (P ¼ .036) and
vibration (P < .001) thresholds, and correlations
Table II. Orofacial pain characteristics (main complaint, pain periods, intensity, and duration of pain) (N ¼ 116)
Groups Main complaint (%) Pain periods (%)
Pain duration in years
(mean  DP)
Pain intensity (VAS)
(mean  DP)
ITN (N ¼ 29) Facial shock-like pain:
20 (69.0)
Daily: 25 (86.2) 5.6  4.9 (1-20) 8.39  2.59 (4-10)
2-3  per week: 4 (13.8)
Intraoral pain: 6 (20.7)
Numbness: 3 (10.3)
TMD (N ¼ 11) Facial pain: 7 (62.6) Daily: 5 (45.5) 9.07  8.32 (1-25) 7.83  1.82 (5-10)
Pain at mandibular
movements: 4 (36.4)
2-3  per week: 5 (45.5)
Monthly: 1 (9.0)
NINP (N ¼ 11) Facial pain: 6 (54.5) Daily: 8 (72.7) 9.23  9.75 (0.8-30) 6.82  3.69 (1-10)
Itching: 1 (9.1) Weekly: 1 (9.1)
Toothache: 1 (9.1) Biweekly: 1 (9.1)
Pain at chewing 1 (9.1) 2-3  per week 1 (9.1)
Numbness 1 (9.1)
Intraoral pain 1 (9.1)
BMS (N ¼ 8) Intraoral pain: 8 (100.0) Daily: 8 (100.0) 4.29  3.90 (1-10) 6.75  3.17 (1-10)
PIFP (N ¼ 8) Facial pain: 8 (100.0) Daily: 8 (100.0) 5.14  1.94 (1-13) 8.63  1.63 (5-10)
Fibromyalgia
(N ¼ 8)
Facial pain: 7 (87.5) Daily: 7 (87.5) 5.25  2.91 (2-11) 9.00  1.71 (5-10)
Pain and numbness: 1 (12.5) 2-3  per week: 1 (12.5)
Total Facial pain: 48 (41.4) Daily: 61 (52.6) 6.27  6.06 (1-30) 8.08  2.64 (1-10)
Intraoral pain 15 (12.9) 2-3  per week 11 (9.5)
Numbness: 5 (4.3) Weekly: 1 (0.9)
Pain at mandibular
function: 2 (1.7)
Biweekly: 1 (0.9)
Itching: 1 (0.9) Monthly: 1 (0.9)
Toothache: 1 (0.9)
P* <.001y <.001 <.001 <.001
ITN, idiopathic trigeminal neuralgia; TMD, temporomandibular disorder; BMS, burning mouth syndrome; PIFP, persistent idiopathic facial pain;
NINP, trigeminal nonidiopathic neuropathic pain; VAS, visual analog scale.
*Chi-square, Fisher’s exact and one-way ANOVA.
yTest Z was used to investigate differences among the groups.
Fig. 1. ITN and NINP had less complaints of generalized pain
than the other patients (N ¼ 116). P ¼ .002, Chi-square test.
ITN, idiopathic trigeminal neuralgia; TMD, temporomandib-
ular disorder; BMS, burning mouth syndrome; PIFP, persis-
tent idiopathic facial pain; NINP, trigeminal nonidiopathic
neuropathic pain. Test Z indicated a lower prevalence of
generalized pain in ITN and NINP than the rest of the patients
and a higher prevalence of generalized pain complaints in
BMS and ﬁbromyalgia than the others.
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pain and gustative thresholds were also positively
correlated (P ¼ .041 and P ¼ .006, respectively).
Women had low sensory thresholds in general
(P < .001), and there was a negative correlation
between ages and thermal (cold and warm) thresholds
(P < .001). High sensory thresholds were associated
with numbness (P ¼ .025) and dysesthesia (P ¼ .039).
High deep pain thresholds were associated with masti-
catory discomfort (P¼ .035), and in all groups of patients,
high pain duration was associated with higher masticatory
discomfort (P ¼ .001), high numbness intensity
(P¼ .003), high dysesthesia intensity (P¼ .002) and high
prevalence of headache (P< .001). The pain intensity was
positively correlated to the intensities of masticatory
discomfort, numbness and dysesthesia (P < .001).
Women had higher pain intensity, higher masticatory
discomfort, more numbness and more dysesthesia
(P< .001) thanmen. Larger pain areas at the pain location
were associated with higher pain intensity (P < .001).
Oral infections were associated with low deep pain
thresholds (P ¼ .016). The symptom of headache was
associated with higher thermal, pain, tactile and vibra-
tion thresholds (P < .030). Masticatory discomfort
intensity was also positively correlated to tactile, sweet
and vibration thresholds (P ¼ .028).DISCUSSION
This study presented the orofacial characteristics and
their association with sensorial ﬁndings of patients with
chronic orofacial pain. Both neuropathic and somatic
diagnoses were included because there are neuroplastic
mechanisms in chroniﬁcation that can provoke changes
Table III. Orofacial pain characteristics (pain descriptors, alleviation and aggravation factors) (N ¼ 116)
Groups Pain descriptors (%) Aggravation factors (%) Alleviation factors (%)
ITN Shock-like: 24 (82.8) Emotional stress: 12 (41.4) Medication: 13 (44.8)
Sharp: 2 (6.9) Cold weather: 9 (31.0) Rest: 3 (10.3)
Shooting: 1 (3.4) Mandibular function: 10 (34.5) Work: 2 (6.9)
Aching: 1 (3.4) Acid food: 1 (3.4) Faith: 1 (3.4)
BMS Burning: 6 (75.0) Feeding: 3 (37.5) Medication: 2 (25.0)
Sharp: 2 (25.0) Emotional stress: 2 (25.0) Sweets and gums: 1 (12.5)
NINP Shock-like: 5 (45.5) Mandibular function: 2 (18.2) Medication: 4 (36.4)
Burning: 4 (36.4) Noise: 1 (9.1) Rest: 2 (18.2)
Sharp: 3 (27.3) Emotional stress: 1 (9.1) Cold: 1 (9.1)
Numbness: 1 (9.1) Cold weather: 1 (9.1) Medication and physiotherapy: 1 (9.1)
Throbbing: 1 (9.1) Spicy food: 1 (9.1)
Heavy: 1 (9.1)
Itchy: 1 (9.1)
Fibromyalgia Burning: 5 (62.5) General daily activities: 7 (87.5) Medication: 5 (62.5)
Throbbing: 4 (50.0) Cold weather and emotional stress: 1 (12.5) Rest: 3 (37.5)
Heavy: 4 (50.0) Massage: 1 (12.5)
Sharp: 4 (50.0)
Shock-like: 3 (37.5)
Tiring: 1 (12.5)
Total Shock-like: 33 (28.4) Mandibular function: 20 (17.2) Medication: 36 (31.0)
Throbbing: 20 (17.2) Emotional stress: 20 (17.2) Rest: 10 (8.6)
Burning: 16 (13.8) Cold weather: 14 (12.1) Massage: 3 (2.6)
Sharp: 16 (13.8) General daily activities: 7 (60.3) Work: 2 (1.7)
Heavy: 13 (11.2) Food: 2 (1.7) Physiotherapy: 1 (0.9)
Tiring: 1 (0.9) Noise: 1 (0.9) Cold: 1 (0.9)
Itchy: 1 (0.9) Warm: 1 (0.9)
Numbness: 1 (0.9) Faith: 1 (0.9)
Shooting: 1 (0.9) Sweets and gums: 1 (0.9)
Aching: 1 (0.9)
P* <.001 <.001 <.001y
ITN, idiopathic trigeminal neuralgia; TMD, temporomandibular disorder; BMS, burning mouth syndrome; PIFP, persistent idiopathic facial pain;
NINP, trigeminal nonidiopathic neuropathic pain.
*Chi-square and one-way ANOVA.
yTest Z was used to investigate differences among the groups.
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ﬁnding in all types of chronic patients, and the careful
investigation of dental and musculoskeletal pains needs
to be done because they can be secondary causes of
pain in such patients. Their treatments present pecu-
liarities and their co-existence with other diagnoses can
obviate adequate pain control.
Among the major results, there was a high preva-
lence of sensorial abnormalities in orofacial pain
patients not only in neuropathic pain (BMS, NINP) but
also in TMD, PIFP and ﬁbromyalgia1,2,7-10,18-20,34;
a high prevalence of masticatory complaints, pain at
craniofacial muscular palpation, unilateral mastication
and worsening of pain with mandibular activity, char-
acterizing myofascial pain secondary to the main
diagnosis (even in patients with neuropathic diagnoses);
and ﬁnally, the association between sensorial distur-
bances with masticatory discomfort and headache.
Somatic pain can cause sensorial discrete impairment
due to mechanisms associated with chroniﬁcation
and neuropathic pain that can generate muscularsensitization and myofascial orofacial pain that needs to
be assessed in these patients. Each of the subjects
carefully evaluated in this population underwent
a complete dental and orofacial exam to identify any
potential cause of pain that could be contributing to the
sensorial and muscular ﬁndings that were observed.
Dental diseases and the loss of teeth can contribute to
the complaints. This type of assessment is relevant for
the clinical practitioner and supported by this study.
Even patients with clear neuropathic conditions, such as
ITN, BMS, or PHN can have dental or musculoskeletal
secondary causes of pain associated that need to be
treated for the alleviation of pain symptoms and relief
of the patients.19,33
There was more perception of numbness in the patient
group. Abnormal sensorial thresholds are often described
in literature in association with neuropathic pain,1,2,12-15
but inﬂammatory conditions also cause primary and
secondary sensitization which affect sensorial percep-
tion.33,35 It would be expected that neuropathic pains in
general are associated with high sensorial abnormalities
Table IV. Oral characteristics at the clinical exam (dental occlusion, oral mucosa and tongue) (N¼116)
Groups Dental occlusion (%) Oral mucosa (%) Tongue (%)
ITN Deep bite: 4 (13.8) Traumatic hyperplasia: 1 (3.4) Fissured: 4 (13.8)
Overjet: 2 (6.9) Ulcer: 1 (3.4) White coating: 5 (17.2)
Coss bite: 2 (6.9) Candidiasis: 1 (3.4) Dry: 2 (6.9)
TMD Open bite: 3 (27.3) Lichen planus: 2 (18.2) Fissured: 1 (9.1)
Dry: 1 (9.1)Deep bite: 2 (18.2)
NINP Deep bite: 1 (9.1) Leukoplakia: 2 (18.2) Erythematosus: 1 (9.1)
Overjet: 1 (9.1)
Deep and cross bite: 1 (9.1)
PIFP Cross bite: 1 (12.5) e Fissured: 2 (25.0)
Deep bite: 2 (25.0)
Overjet: 1 (12.5)
Fibromyalgia Deep bite: 2 (25.0) Ulcer: 1 (12.5) Fissured: 3 (37.5)
Dry: 1 (12.5)
Controls Overjet: 1 (2.4) Ulcer: 2 (4.9) Fissured: 14 (34.2)
Cross bite: 5 (12.2) Traumatic hyperplasia: 1 (2.4) White coating: 6 (14.7)
Open bite: 1 (2.4) Candidiasis: 1 (2.4)
Deep bite: 1 (2.4)
Total Deep bite: 16 (13.8) Ulcer: 5 (4.3) Fissured: 29 (25.0)
Cross bite: 9 (7.8) Leukoplakia: 2 (1.8) White coating: 12 (10.3)
Open bite: 5 (4.3) Lichen planus: 2 (1.8) Dry: 4 (3.3)
Overjet: 5 (4.3) Traumatic hyperplasia: 2 (1.8) Erythematosus: 1 (0.9)
Candidiasis: 2 (1.8)
P* .400 .080 .127
ITN, idiopathic trigeminal neuralgia; TMD, temporomandibular disorder; BMS, burning mouth syndrome; PIFP, persistent idiopathic facial pain;
NINP, trigeminal nonidiopathic neuropathic pain.
*Chi-square.
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of special sensorial modalities (gustation and olfaction)
has been extensively discussed in the last decades and it is
a clear evidence of the sensorial interaction at the
craniofacial territory.7,20-22
Musculoskeletal impairment can be considered in part
a sign of secondary sensitization, and its presence can be
responsible for at least part of the pain complaint.33
Patients with unsuccessful treatments should be better
investigated to look for associated causes of pain.
Neuropathic diagnoses have low response to the thera-
pies and recognizing a somatic cause of pain in associ-
ation can help in the alleviation of symptoms.
There were no differences in dental and oral char-
acteristics between the patients and the controls, except
for high prevalence of dryness at the oral mucosa and
ﬁssured tongue in BMS.21,22 One intriguing aspect is
the higher prevalence of bruxism among the patients
compared with controls, which could be also secondary
to neuroplasticity and central sensitization of chronic
pain (bruxism is currently associated to central neural
physiopathology).35
Finally, headache and generalized pain complaints
were frequent in these patients. Headache was associated
withmasticatory discomfort and the possiblemechanisms
underlying it had been already discussed. Generalized
complaints of pain were very common in all groups of
patients and can also reﬂect high central sensitization.
This deserves attention because patients with moregeneralized pain complaints could be the ones that are
susceptible to develop systemic conditions such as
ﬁbromyalgia.19
Some limitations of this study were the heterogeneity
of the sample, resulting in small subgroups. These
patients were not excluded or mixed into other pain
groups for 2 reasons. The most important reason is that
each singular condition may affect the sensory and
masticatory systems in a particular way and, although
some studies had investigated speciﬁc diseases, none or
few had compared patients with the same method (clin-
ical and sensorial). Another limitation is that some
patients were taking medications with action on the
central nervous system and these activities could have
affected the sensorial results and their level of pain. Also,
there were age differences among the groups of patients,
and the control group had more men than the patient
group. Finally, there were gender differences in pain
perception and in somatosensory thresholds detection
which could have interfered in the observed results.
Conclusion
In conclusion, muscular sensitivity and sensorial ﬁnd-
ings can be observed in orofacial pain patients and may
be underlying neuroplastic changes in both neuropathic
and non-neuropathic pain conditions. Somatic pain can
also cause sensorial dysfunction due to chroniﬁcation
and become at least in part neuropathic. These factors
can be secondary contributors of pain.
Fig. 2. Thermal QST (A, cold; B,warm): means and error bars
(N ¼ 116). A, Cold. B, Tactile. ITN, idiopathic trigeminal
neuralgia; TMD, temporomandibular disorder; BMS, burning
mouth syndrome;PIFP, persistent idiopathic facial pain;NINP,
trigeminal nonidiopathic neuropathic pain. One-way ANOVA,
conﬁdence interval (95%): A, P ¼ .017: BMS and NINP had
higher thresholds than the controls. B, P ¼ .048: DFIP had
higher tactile thresholds than the controls. Dark circle means
outlier. *Statistical difference when compared with control.
Fig. 3. Pain QST (A, deep; B, superﬁcial): means and error
bars (N ¼ 116). A, Deep. B, Superﬁcial. ITN, idiopathic
trigeminal neuralgia; TMD, temporomandibular disorder;
BMS, burning mouth syndrome; PIFP, persistent idiopathic
facial pain; NINP, trigeminal nonidiopathic neuropathic pain.
One-way ANOVA, conﬁdence interval (95%): A, P < .001:
DFIP and TMD had lower deep pain thresholds than the
controls. B, P ¼ .002: DFIP and ﬁbromyalgia had higher
superﬁcial pain thresholds than the controls. Dark circle means
outlier. *Statistical difference when compared with control.
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